Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
MELA > SEC Filings for MELA > Form 8-K on 21-Feb-2014All Recent SEC Filings

Show all filings for MELA SCIENCES, INC. /NY

Form 8-K for MELA SCIENCES, INC. /NY


21-Feb-2014

Other Events, Financial Statements and Exhibits


Item 8.01 - Other Events

A. On August 22, 2013, The NASDAQ Stock Market ("Nasdaq") notified MELA Sciences, Inc. (the "Company") that for the previous 30 consecutive business days, the Company was not in compliance with Rule 5550(a)(2) of the Nasdaq Listing Rules. Rule 5550(a)(2) requires the Company's common stock to maintain a minimum bid price of $1.00 per share. Therefore, under Nasdaq's continued listing requirements, a deficiency existed. The notification had no immediate effect on the listing of the Company's common stock.

Nasdaq Listing Rule 5810(c)(3)(A) provided the Company with an automatic grace period of 180 days, which ended on February 18, 2014, in order to regain compliance with the minimum bid price requirement. On February 19, 2014, Nasdaq notified the Company that while the Company had not regained compliance with the minimum bid price requirement, it was eligible for an additional 180 day grace period, until August 18, 2014, to regain compliance with the minimum bid price requirement.

Nasdaq has informed the Company that in the event the Company is unable to regain compliance with the minimum bid price requirement by August 18, 2014, Nasdaq will provide written notification to the Company that its securities will be delisted. At that time, the Company may appeal the delisting determination to a Nasdaq Hearings Panel. The Company will monitor the closing bid price of its common stock and will consider various possible options if it does not appear that it will regain compliance by August 18, 2014.

B. The Company gave a presentation at the SeeThruEquity Winter Microcap Investor Conference. A copy of the transcript of the presentation given by Rose Crane, the Company's President and Chief Executive Officer, is attached hereto as Exhibit 99.1.



Item 9.01 - Financial Statements and Exhibits

(d) Exhibits

99.1 Transcript of presentation given at the SeeThruEquity Winter Microcap Investor Conference held on February 6, 2014


  Add MELA to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for MELA - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.